BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38319987)

  • 1. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
    Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
    Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis.
    Jiang ZY; Zhou Y; Zhou L; Li SW; Wang BM
    Biomed Res Int; 2021; 2021():7561645. PubMed ID: 34552988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
    Li LY; Wu JX
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
    [No Abstract]   [Full Text] [Related]  

  • 6. Microarray-Based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease: A Protein-Protein Interaction Network Analysis.
    Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2023 May; ():. PubMed ID: 37194229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis.
    He J; Zhang X; Chen X; Xu Z; Chen X; Xu J
    Glob Med Genet; 2023 Sep; 10(3):144-158. PubMed ID: 37501756
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.
    Jiang H; Hu Y; Zhang Z; Chen X; Gao J
    Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
    Fan GH; Wei RL; Wei XY; Zhang CZ; Qi ZT; Xie HY; Zheng SS; Xu X
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):433-451. PubMed ID: 34233850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease.
    Wu C; Zhou Y; Wang M; Dai G; Liu X; Lai L; Tang S
    Front Genet; 2021; 12():772487. PubMed ID: 34777484
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Key Biomarkers in Hepatocellular Carcinoma Induced by Non-alcoholic steatohepatitis or Metabolic Syndrome via Integrated Bioinformatics Analysis.
    Wang B; Zhang Y; Gai L; He Y; Qiu H; Li P
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):174-180. PubMed ID: 37715392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
    Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics.
    Chen Y; Qian H; He X; Zhang J; Xue S; Wu Y; Chen J; Wu X; Zhang S
    J Oncol; 2022; 2022():2515513. PubMed ID: 36199789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.
    Ma M; Xie W; Li X
    Int J Gen Med; 2021; 14():3163-3176. PubMed ID: 34262330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
    Wu M; Liu Z; Zhang A; Li N
    Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.